-transparent.png){kind=logo}
Multiple dosing four times daily for 7 days of indoprofen 200 mg, a non-steroidal anti-inflammatory drug with a short half-life (t1/2), revealed drug accumulation in eight elderly subjects. This indicates a substantially longer t1/2 (11 h) than that reported in young persons (3 h). A reduction in dose compared to younger subjects is recommended in elderly patients with osteoarthritis.
Related Publications
B Lund, and
C Egsmose, and
O Knudsen, and
R B Andersen
October 2005,
Current Alzheimer research,
B Lund, and
C Egsmose, and
O Knudsen, and
R B Andersen
September 1996,
Journal of clinical pharmacology,
B Lund, and
C Egsmose, and
O Knudsen, and
R B Andersen
November 2000,
The Journal of the Association of Physicians of India,
B Lund, and
C Egsmose, and
O Knudsen, and
R B Andersen
November 2001,
The Journal of the Association of Physicians of India,
B Lund, and
C Egsmose, and
O Knudsen, and
R B Andersen
June 2005,
Expert opinion on drug metabolism & toxicology,
B Lund, and
C Egsmose, and
O Knudsen, and
R B Andersen
September 1987,
Journal of clinical pharmacology,
B Lund, and
C Egsmose, and
O Knudsen, and
R B Andersen
February 1987,
Arquivos brasileiros de cardiologia,
B Lund, and
C Egsmose, and
O Knudsen, and
R B Andersen
September 1977,
International journal of clinical pharmacology and biopharmacy,
B Lund, and
C Egsmose, and
O Knudsen, and
R B Andersen
December 1985,
British journal of clinical pharmacology,
B Lund, and
C Egsmose, and
O Knudsen, and
R B Andersen
June 1998,
European journal of clinical pharmacology,
